OAKBX
Price
$37.81
Change
+$0.12 (+0.32%)
Updated
Oct 17 closing price
Net Assets
6.24B
RIDEX
Price
$27.45
Change
+$0.01 (+0.04%)
Updated
Oct 17 closing price
Net Assets
138.68B
Interact to see
Advertisement

OAKBX vs RIDEX

Header iconOAKBX vs RIDEX Comparison
Open Charts OAKBX vs RIDEXBanner chart's image
Oakmark Equity And Income Investor
Price$37.81
Change+$0.12 (+0.32%)
VolumeN/A
Net Assets6.24B
American Funds Income Fund of Amer R4
Price$27.45
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets138.68B
OAKBX vs RIDEX Comparison Chart in %
View a ticker or compare two or three
VS
OAKBX vs. RIDEX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAKBX is a Hold and RIDEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIDEX has more cash in the bank: 139B vs. OAKBX (6.24B). RIDEX pays higher dividends than OAKBX: RIDEX (3.52) vs OAKBX (2.14). OAKBX was incepted earlier than RIDEX: OAKBX (30 years) vs RIDEX (23 years). OAKBX (0.85) is less costly to investors than RIDEX (0.61). OAKBX has a lower initial minimum investment than RIDEX: OAKBX (0) vs RIDEX (250). RIDEX annual gain was more profitable for investors over the last year : 9.15 vs. OAKBX (6.30). OAKBX return over 5 years is better than : 43.96 vs. RIDEX (40.70).
OAKBXRIDEXOAKBX / RIDEX
Total Expense Ratio0.850.61139%
Annual Report Gross Expense Ratio0.850.61139%
Fund Existence30 years23 years-
Gain YTD6.98414.83247%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.24B139B4%
Annual Yield % from dividends2.143.5261%
Returns for 1 year6.309.1569%
Returns for 3 years39.1337.83103%
Returns for 5 years43.9640.70108%
Returns for 10 years35.8457.2163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI46.350.64
+1.40%
Acadian Asset Management Inc
YHNAU10.45N/A
N/A
YHN Acquisition I
CORT78.69-0.78
-0.98%
Corcept Therapeutics
VALU38.45-0.48
-1.23%
Value Line
ACRV1.81-0.06
-3.21%
Acrivon Therapeutics